Holdings in Company

RNS Number : 5489Y

Arix Bioscience Plc

06 March 2017

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESⁱ


1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ⁱⁱ		ARIX BIOSCIENCE PLC
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights			X
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the notification obligation: ⁱⁱⁱ	Takeda Ventures, Inc.
4. Full name of shareholder(s) (if different from 3.):^iv
5. Date of the transaction and date on which the threshold is crossed or reached: ^v	17/02/2017
6. Date on which issuer notified:	02 March 2017
7. Threshold(s) that is/are crossed or reached: ^{vi, vii}	5%

8. Notified details:

A: Voting rights attached to shares ^{viii, ix}

Class/type of
shares

if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

%of voting rights^x

Direct

Direct ^xi

Indirect ^xii

Direct

Indirect

Ordinary Shares

GB00BD045074

0.00

4,830,917

5.4%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date ^xiii

Exercise/
Conversion Period ^xiv

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

% of voting
rights

N/A

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments ^{xv, xvi}

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise price

Expiration date ^xvii

Exercise/
Conversion period ^xviii

Number of voting rights instrument refers to

% of voting rights ^{xix, xx}

N/A

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

4,830,917

5.4%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: ^xxi


Proxy Voting:
10. Name of the proxy holder:		none
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:
14. Contact name:	Michael Martin, Ph.D.
15. Contact telephone number:	+1 650 328 2900

Note: Annex should only be submitted to the FCA not the issuer

Annex: Notification of major interests in sharesxxii

A: Identity of the persons or legal entity subject to the notification obligation
Full name (including legal form of legal entities)	Takeda Ventures, Inc.
Contact address (registered office for legal entities)	435 Tasso Street, Suite 300 Palo Alto, CA 94301 USA
Phone number & email	Phone: +1 650 328 2900 E-mail: contact@tri-takeda.com
Other useful information (at least legal representative for legal persons)

B: Identity of the notifier, if applicable
Full name	Michael Martin, Ph.D.
Contact address	435 Tasso Street, Suite 300 Palo Alto, CA 94301 USA
Phone number & email	Phone: +1 650 328 2900
Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation)	President